Medications

Diabetes drugs like Ozempic lower cancer risks: Study

A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.

Medications

Popular diabetes drugs may reduce the risk of dementia

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet published in the journal eClinicalMedicine.

Cardiology

New approach against fatty liver: Molecular pathway identified

Fatty liver disease (SLD) is increasingly causing failure of the liver as a vital organ. A team led by researchers from the Institute of Metabolic Physiology at Heinrich Heine University Düsseldorf (HHU) in collaboration ...

page 1 from 6